Minnesota House Bill HF1100

Minnesota 2025 1st Special Session

Caption

Commissioner of human services required to establish a directed pharmacy dispensing payment to improve and maintain access to pharmaceutical services, and money appropriated.

Summary

HF1100 requires the Minnesota Commissioner of Human Services to establish a directed pharmacy dispensing payment of $4.50 per filled prescription for eligible outpatient retail pharmacies serving Medical Assistance enrollees. The payment is intended to improve and maintain access to pharmaceutical services in rural and underserved areas. It applies to managed care and county-based purchasing plans, and to pharmacy benefit managers under contract with those plans, which must make the payment to qualifying pharmacies in addition to existing dispensing fees. The bill defines eligible pharmacies as licensed outpatient retail pharmacies that are not owned by a pharmacy benefit manager or health carrier and that either are located in a medically underserved area or primarily serve a medically underserved population, or share common ownership with 12 or fewer Minnesota pharmacies. Pharmacies must attest to eligibility on a commissioner-developed form. The commissioner is authorized to adjust the payment amount based on available state and federal funding, and must monitor the effect of the requirement on access to pharmacy services. The bill also includes a contingency for federal approval: if approval is not received for a contract year, capitation rates must be adjusted and contracts must allow recovery of related payments, with the subdivision expiring if federal approval is never obtained. The new provision is effective July 1, 2025, or upon federal approval, whichever is later, and the bill appropriates general fund money in fiscal years 2026 and 2027 for the payments.

Impact

HF1100 would amend Minnesota Statutes section 256B.69 by adding a new subdivision governing Medical Assistance managed care pharmacy reimbursement. It would create a new state-directed payment requirement for eligible rural and underserved retail pharmacies, affect managed care and county-based purchasing contracts, and require coordination with pharmacy benefit managers. The bill also creates a new state appropriation for the Department of Human Services and could affect capitation rate-setting, contract terms, and pharmacy reimbursement practices if federal approval is granted.

Sentiment

Based on the bill text and the absence of recorded committee testimony or votes in the provided materials, the bill appears to be framed positively as an access-to-care measure. Its stated purpose is to preserve pharmacy access in rural and underserved communities, suggesting support for community pharmacies and patients who rely on them. No formal vote history or transcript is available here to show opposition or amendment activity.

Contention

The main likely points of contention are the cost and structure of the directed payment, including whether the $4.50 per prescription amount is sufficient, excessive, or should be adjusted by the commissioner. Another potential issue is the exclusion of pharmacies owned by pharmacy benefit managers or health carriers, which may be seen as favoring independent and smaller chain pharmacies over vertically integrated entities. Managed care plans, county-based purchasing plans, and pharmacy benefit managers may also object to the administrative and financial obligations, while supporters are likely to emphasize rural access, underserved populations, and independent pharmacy viability.